January 10, 2020
Silva MA et al. J Pathol Clin Res 2020;6(2):124-137.
Biomarker recommendation for PD‐1/PD‐L1 immunotherapy development in pediatric cancer based on digital image analysis of PD‐L1 and immune cells.
You might also be interested by
CellTalk Blog
Optimal FFPE Tissue Fixation, Processing, and Embedding: A Comprehensive Guide
September 4, 2024
Histopathology
More infoCellTalk Blog
Optimizing your in situ hybridization for success
August 30, 2024
Histopathology
More infoScientific Publications
Fibroblast Activation Protein-a and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression
August 5, 2024
Histopathology
More infoBrochures & Infographics
Immunohistochemistry (IHC) Biomarker List
February 29, 2024
Histopathology
More info